Quick Answer
Bio Essence Corp reported Net Income Loss of $896.2 thousand for the year ending 2025.
- Bio Essence Corp showed an increase of +168.5% in Net Income Loss from 2024 to 2025.
- This data is from Bio Essence Corp's annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: -$117.1 thousand | Q2 2020: -$184.4 thousand | Q3 2020: -$204.7 thousand | Q1 2021: -$210.4 thousand | Q2 2021: -$163.5 thousand | Q3 2021: -$183.0 thousand | Q1 2022: -$233.1 thousand | Q2 2022: -$164.2 thousand | Q3 2022: -$199.2 thousand | Q1 2023: -$178.8 thousand | Q2 2023: -$284.5 thousand | Q3 2023: -$314.8 thousand | Q1 2024: $133.9 thousand | Q2 2024: -$215.7 thousand | Q3 2024: -$1.20 million | Q1 2025: -$205.8 thousand | Q2 2025: $59.9 thousand | Q3 2025: $13.0 thousand.
- Over the full 6 years of available data (2020 to 2025), Bio Essence Corp's Net Income Loss has grown by 250.4%.
- Historical annual values: Fiscal year 2025: $896.2 thousand | Fiscal year 2024: -$1.31 million | Fiscal year 2023: -$971.9 thousand | Fiscal year 2022: -$809.7 thousand | Fiscal year 2021: -$647.6 thousand | Fiscal year 2020: -$595.8 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: